Trial NCT03529084

View at ClinicalTrials.gov 
Org. Study IDs: CEGF816A2302
Secondary IDs: 2017-003998-34

Last trial update was posted on 2019-11-22

MeSH Interventions

Erlotinib Hydrochloride Gefitinib Nazartinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

Carcinoma, Non-small Cell Lung

Stopping Reasons

Decision by Sponsor not to continue with the trial.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID